XML 59 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
Joint Ventures
6 Months Ended
Mar. 31, 2013
Joint Ventures
Joint Ventures

The Company participates in a 50% joint venture, ULVAC Cryogenics, Inc. (“UCI”), with ULVAC Corporation of Chigasaki, Japan. UCI manufactures and sells cryogenic vacuum pumps, principally to ULVAC Corporation. For the three months ended March 31, 2013 and 2012, the Company recorded income (expense) associated with UCI of $(16,000) and $0.6 million, respectively. For the six months ended March 31, 2013 and 2012, the Company recorded income associated with UCI of $62,000 and $1.5 million, respectively. At March 31, 2013, the carrying value of UCI in the Company’s consolidated balance sheet was $25.1 million. For the three months ended March 31, 2013 and 2012, management fee payments received by the Company from UCI were $0.1 million and $0.2 million, respectively. For the six months ended March 31, 2013 and 2012, management fee payments received by the Company from UCI were $0.2 million and $0.6 million, respectively. For the three months ended March 31, 2013 and 2012, the Company incurred charges from UCI for products or services of $0.1 million and $0.2 million, respectively. For the six months ended March 31, 2013 and 2012, the Company incurred charges from UCI for products or services of $0.4 million and $0.5 million, respectively. At March 31, 2013 and September 30, 2012 the Company owed UCI $34,000 and $0.1 million, respectively, in connection with accounts payable for unpaid products and services. Summarized condensed financial information for UCI is as follows (in thousands):


 
Three Months Ended
December 31,
 
Six Months Ended
December 31,
 
2012
 
2011
 
2012
 
2011
Statements of Operations:


 


 


 


Revenue
$
8,619

 
$
18,196

 
$
18,879

 
$
43,928

Gross profit
2,409

 
5,135

 
5,660

 
12,807

Net income (loss)
(33
)
 
1,219

 
123

 
2,951



The Company participates in a 50% joint venture with Yaskawa Electric Corporation (“Yaskawa”) called Yaskawa Brooks Automation, Inc. (“YBA”) to exclusively market and sell Yaskawa’s semiconductor robotics products and Brooks’ automation hardware products to semiconductor customers in Japan. For the three months ended March 31, 2013 and 2012, the Company recorded income (expense) associated with YBA of $6,000 and $(0.2) million respectively. For the six months ended March 31, 2013 and 2012, the Company recorded income (expense) associated with YBA of $(78,000) and $5,000, respectively. At March 31, 2013, the carrying value of YBA in the Company’s consolidated balance sheet was $3.3 million. For the three months ended March 31, 2013 and 2012, revenues earned by the Company from YBA were $1.3 million and $1.9 million, respectively. For the six months ended March 31, 2013 and 2012, revenues earned by the Company from YBA were $2.9 million and $4.0 million, respectively. For the three months ended March 31, 2013 and 2012, the Company incurred charges from YBA for products or services of $0.2 million and $0.1 million, respectively. For the six months ended March 31, 2013 and 2012, the Company incurred charges from YBA for products or services of $0.3 million and $0.2 million, respectively.
The amount due from YBA included in accounts receivable at March 31, 2013 and September 30, 2012 was $1.4 million and $2.0 million, respectively. At March 31, 2013 and September 30, 2012 the Company owed YBA $0.1 million in connection with accounts payable for unpaid products and services. Summarized condensed financial information for YBA is as follows (in thousands):
 
 
Three Months Ended
March 20,
 
Six Months Ended
March 20,
 
2013
 
2012
 
2013
 
2012
Statements of Operations:


 


 


 


Revenue
$
13,908

 
$
22,538

 
$
26,947

 
$
46,261

Gross profit
1,671

 
1,896

 
3,495

 
4,246

Net loss
(21
)
 
(236
)
 
(116
)
 
(148
)


These investments are accounted for using the equity method. Under this method of accounting, the Company records in income a proportionate share of the earnings of the joint ventures with a corresponding increase in the carrying value of the investment.